journal article·2009-07

Injectable in situ forming drug delivery system based on poly(ε-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti-cancer evaluation

Shahriar Sharifi, Hamid Mirzadeh, Mohammad Imani, Zimei Rong, Ahmad Jamshidi, Mohammadali Shokrgozar, Mohammad Atai, Nima Roohpour

Acta Biomaterialia· Volume 5· Issue 6
Publisher page

Abstract

The present study deals with the preparation and characterization of an injectable and in situ forming drug delivery system based on photocrosslinked poly(epsilon-caprolactone fumarate) (PCLF) networks loaded with tamoxifen citrate (TC). Networks were made of PCLF macromers, a photoinitiation system (comprising initiator and accelerator) and the active ingredient N-vinyl-2-pyrrolidone (NVP) as a crosslinker and reactive diluent. Shrinkage behavior, equilibrium swelling and sol fraction ratios of photocrosslinked PCLF gels were determined as functions of NVP content. It was shown that the crosslinking is facilitated up to a certain concentration of NVP and most of NVP remained unreacted above this value. In vitro drug release, biocompatibility evaluation and activity against MCF-7 breast cancer cell line were also investigated. Accurate but simple bipartite expressions were also derived that enable rapid determination of effective diffusion coefficients of TC in photocrosslinked PCLF/NVP disks. Cytotoxicity assay showed that while the photocrosslinked PCLF network with optimum NVP content exhibits no significant cytotoxicity against MCF-7 and L929 cell lines, 40-60% of the MCF-7 cells were killed after incubation with TC-loaded devices.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: biodegradable polymer synthesis and properties · Hydrogels: synthesis, properties, applications · Advanced Polymer Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Polyanhydride modified unsaturated polyesters as injectable drug carriers: synthesis and antitumor efficacy in Sarcoma-180 mice bearing tumor10.1016/j.polymdegradstab.2006.08.022 ↗
2. Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation10.1016/j.ejpb.2006.11.022 ↗
3. Antitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride10.1016/j.ejpb.2007.03.020 ↗
4. Polymeric implants for cancer chemotherapy10.1016/S0169-409X(97)00036-7 ↗
5. Controlled release of paclitaxel from biodegradable unsaturated poly(ester amide)s/poly(ethylene glycol) diacrylate hydrogels10.1163/156856207780852569 ↗
6. Synthesis, characterization of novel injectable drug carriers and the antitumor efficacy in mice bearing Sarcoma-180 tumor10.1016/j.jconrel.2005.06.021 ↗
7. In situ hydrogelation of photocurable gelatin and drug release10.1002/jbm.1237 ↗
8. New unsaturated polyesters as injectable drug carriers10.1016/j.polymdegradstab.2006.11.018 ↗
9. Biodegradable injectable in situ forming drug delivery systems10.1016/S0168-3659(02)00008-1 ↗
10. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release10.1016/S0168-3659(98)00125-4 ↗
11. Controlled-release of IGF-I and TGF-β1 in a photopolymerizing hydrogel for cartilage tissue engineering10.1016/S0736-0266(01)00054-7 ↗
12. Controlled release from crosslinked degradable networks10.1615/CritRevTherDrugCarrierSyst.v19.i45.30 ↗
13. A review of photocrosslinked polyanhydrides: in situ forming degradable networks10.1016/S0142-9612(00)00107-1 ↗
14. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(alpha hydroxyl acid) diacrylate macromers10.1021/ma00056a005 ↗
15. Photoinitiated crosslinked degradable copolymer networks for tissue engineering applications10.1016/S0142-9612(02)00582-3 ↗
16. New directions in photopolymerizable biomaterials10.1557/mrs2002.49 ↗
17. Photopolymerizable hydrogels for tissue engineering applications10.1016/S0142-9612(02)00175-8 ↗
18. Hydrogel formation by photocrosslinking of dimethylmaleimide functionalized polyacrylamide10.1016/j.polymer.2007.07.013 ↗
19. Anseth · 1997 · 189
20. Photocrosslinkable polysaccharides for in situ hydrogel formation10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q ↗
21. Unsaturated polyester resins: chemistry and technology10.1007/b136243 ↗
22. Synthesis and characterization of a block copolymer consisting of poly(propylene fumarate) and poly(ethylene glycol)10.1021/ma970312v ↗
23. Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer10.1021/ma001563y ↗
24. Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells10.1177/096368979900800402 ↗
25. Poly(propylene fumarate)
26. Synthesis and properties of photo crosslinked poly(propylene fumarate) scaffolds10.1163/156856201316883476 ↗
27. Evaluation of thermal- and photo-crosslinked biodegradable poly(propylene fumarate)-based networks10.1002/jbm.a.10011 ↗
28. Synthesis, material properties, and biocompatibility of a novel self-crosslinkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold10.1021/bm050206y ↗
29. Photo-cross-linked hybrid polymer networks consisting of poly(propylene fumarate) and poly(caprolactone fumarate): controlled physical properties and regulated bone and nerve cell responses10.1021/bm7012313 ↗
30. Synthesis and characterizations of biodegradable and crosslinkable poly(ε-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer10.1016/j.biomaterials.2005.07.013 ↗
31. Photopolymerization and shrinkage kinetics of injectable, in situ crosslinkable vinyl pyrrolidone/poly(ε-caprolactone fumarate) networks10.1002/jbm.a.31384 ↗
32. Synthesis, photocrosslinking characteristics and biocompatibility evaluation of NVP/poly(ε-caprolactone fumarate) biomaterials using a new proton scavenger10.1002/pat.1207 ↗
33. Effect of macromer molecular weight on in vitro ophthalmic drug release from photo-crosslinked matrices10.1016/j.actbio.2007.08.011 ↗
34. Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers10.1016/j.jconrel.2006.05.024 ↗
35. Basic guide to the mechanisms of antiestrogen action10.1016/S0031-6997(24)01358-9 ↗
36. Early discontinuation of tamoxifen: a lesson for oncologists10.1002/cncr.22485 ↗
37. Kinetic measurements of photo-polymerization contraction in resins and composites10.1088/0957-0233/2/8/013 ↗
38. Shrinkage strain-rates of dental resin-monomer and composite systems10.1016/j.biomaterials.2005.01.022 ↗
39. Statistical mechanics of cross-linked polymer networks10.1063/1.1723791 ↗
40. Lingois P, Berglund L, Maffezoli A. Chemically induced residual stresses in dental composites. In: International scientific colloquium, modeling for saving resources, Riga, May 17–18; 2001. p. 72–6.
41. Jamshidi A, Sharfi SH, Mirzadeh H, Imani M. HPTLC determination of tamoxifen citrate in drug release media of in situ crosslinking delivery. J Planner Chromatogr, in press.
42. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity10.1016/j.jconrel.2005.03.006 ↗
43. Effects of composition and reactivity on the reaction kinetics of dimethacrylate/dimethacrylate copolymerizations10.1021/ma990258d ↗
44. Subchronic inhalation and oral toxicity of N-vinylpyrrolidone 2. Studies in rodents10.1016/S0278-6915(97)87274-2 ↗
45. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel10.1248/cpb.49.1444 ↗
46. Poly(ε-caprolactone) and its copolymers
47. Effective diffusion coefficient determination within cylindrical granules of adsorbents using a direct simulation method10.1016/j.jcis.2007.04.070 ↗
48. Simple expressions for diffusion coefficient determination of adsorption within spherical and cylindrical absorbents using direct simulation method10.1016/j.jcis.2006.07.041 ↗
49. A unified mathematical model for diffusion from drug–polymer composite tablets10.1002/jbm.820100507 ↗